The thienopyridine class of antiplatelet drugs

Zane Kaplan, Saheb Al-Daher, Hatem H. Salem

Research output: Contribution to journalReview ArticleResearchpeer-review


The newer agents of the platelet ADP-receptor blocking class of antiplatelet drugs have greater antiplatelet efficacy and are less prone to cytochrome P450-related drug interactions than clopidogrel but are associated with an increased risk of haemorrhagic complications.

Original languageEnglish
Pages (from-to)65-70
Number of pages6
JournalMedicine Today
Issue number8
Publication statusPublished - Aug 2010

Cite this